Suprachoroidal silicone tube shunt implantation successful in glaucoma surgery

Article

Suprachoroidal silicone tube drainage of aqueous humour effectively reduces intraocular pressure (IOP) in glaucoma patients

Suprachoroidal silicone tube drainage of aqueous humour effectively reduces intraocular pressure (IOP) in glaucoma patients, according to a study published in the Journal of Glaucoma.

Dr Metin Unal et al., Ulucanlar Eye Education and Research Hospital, Ankara, Turkey, studied 24 glaucomatous eyes that were unresponsive to medical treatment, including 7 eyes that underwent earlier trabeculectomy. A limbus-based scleral flap and a 1.5 mm deep sclerotomy adjacent to the flap opening was created. The posterior end of the tube was placed in the suprachoroidal space and the anterior end was put into the anterior chamber. IOP and best corrected visual acuities (BCVA) were measured preoperatively and postoperatively on the first day, then the first week and in the first, third, sixth, twelfth and eighteen months.

The tube was considered as a failure if postoperative IOP was greater than 21 mm Hg, lower than 5 mm Hg or if additional surgery was required. Eyes that did not require supplemental medical therapy were identified as a complete success. Eyes that had an IOP within the range, regardless of whether they had additional medical therapy, were considered as a qualified success.

After a mean postoperative follow-up period of 4.4±23.7 weeks, the mean IOP had significantly reduced compared to preoperative data. Results demonstrated a complete success rate of 95.8%±4.1 in the first week, 79.2%±8.3 in the first and the third months, and 63.3%±12.0 for the sixth and twelfth month. Qualified success rates were 95.8%±4.1 in the first week, 87.5%±6.8 in the first, third, sixth, twelfth months. Of the eyes studied, 7 were classed as failures and early hypotony was identified in 6 eyes. Intracameral bleeding was found in 2 patients and 3 patients experienced a fibrin reaction in the anterior chamber. There was no record of infection, choroidal or retinal detachment. The suprachoroidal silicone tube shunt implantation is a safe and effective treatment for glaucoma patients.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2025 MJH Life Sciences

All rights reserved.